Find premium clean technology reports - docstoc

DocStore » Research Reports » Clean Technology

Per Page: 15 25 50

2...

TetraLogic Pharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company, based in the US. It discovers and develops small molecule drugs for the treatment of cancer. The company’s smac mimetic drug, birinapant, is entering phase 2 clinical trials and is being developed for both solid tumors and hematological malignancies as a single agent and in combination with several standard-of-care cancer therapies. Its birinapant is a small molecule peptidomimetic of smac that is mechanistically differentiated from other classes of cancer drugs. TetraLogic’s products include TL32711, a smac mimetic drug for solid tumors and hematological malignancies. The company was incorporated in the year 2003. TetraLogic is headquartered in Malvern, Pennsylvania, the US.
PhaseBio Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

PhaseBio Pharmaceuticals, Inc. (PhaseBio) is a pharmaceutical company, based in the US. The company develops new and improved drugs with an initial focus on endocrine, metabolic and cardiovascular disease. It uses a class of recombinant biopolymers such as, elastin-like polymers (ELPs) to improve the stability, bioavailability, activity and ease of administration of proteins and peptides that is clinically active with the goal of achieving greater drug potency, fewer side effects and better patient compliance. The product pipeline of PhaseBio include therapeutic focus - type 2 diabetes and obesity, therapeutic focus - hypertension and cardiovascular disease, glymera, vasomera and insumera. The technologies of the company include Advantages of ELP Biopolymers and ELP Nanoparticles for Delivery of Small Molecule Drugs. It is collaborated with the academic research centers and major pharmaceutical companies. PhaseBio is headquartered in Malvern, Pennsylvania, the US.
Cavit Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Cavit Sciences, Inc. (Cavit Sciences) is a biotechnology company, based in the US. The company has develops therapeutic treatment for cancer and viral infections. It develops and commercializes intellectual property rights for the treatment and inhibition of various major diseases such as viral infections and cancer. Cavit Sciences’s products include tubercin, SSM and derivatives. The company has entered into contracts with McCoy Enterprises LLC to finalize merger agreement. It has signed agreements with Americare Nutritional Division and Daycon Investors Associates, Inc, to acquire food supplement line. It has completed the takeover of National Health Services. Cavit Sciences is headquartered in Paterson, New Jersey, the US.
OncoMed Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

OncoMed Pharmaceuticals, Inc. (OncoMed) is a biotechnology company. It carries out the discovery and development of monoclonal antibody therapeutics. The company's development pipeline includes anti-DLL4, anti-DLL4/VEGF bispecific, anti-notch2/3, anti-notch1, anti-Fzd7, Fzd8Fc, Wnt SMOLs and new pathways. It has three anti-CSC product candidates in clinical development. The company has partnerships with GlaxoSmithKline and Bayer HealthCare. OncoMed is headquartered in Redwood City, California, the US.
Cato Research Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Cato Research Ltd. (Cato Research) is a healthcare service company, based in the US. The company provides research and development services to pharmaceutical and biotechnology industry. Its services include design and execution of regulatory strategy, management and monitoring of preclinical and toxicology studies, management of data processing, design and implementation of preclinical development programs. Cato Research provides others services such as preparation, compilation and submission of grants and management and conduct of due diligence activities for emerging technologies. The company has its presence in Israel, Germany, Austria, Latvia, South Africa and the US. It operates as a subsidiary of Cato Holding Company. Cato Research is headquartered in Durham, North Carolina, the US.
Opsona Therapeutics Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Opsona Therapeutics Ltd. (Opsona) is a pharmaceutical and healthcare company, based in Ireland. The company develops a range of drugs and vaccines to treat and prevent autoimmune and inflammatory diseases as well as technology for cancers and infectious diseases. Its products include OPN-305, inflammasome and opsovac. The company’s product pipeline in a range of phases of development include inflammasome, a small molecule program to inhibit 1L-1 ß production; OPN-305, and a compound that reduces pro-inflammatory cytokine production connected with heart and kidney diseases. Its financial partners include Novartis Venture Fund, Inventages Venture Capital, Seroba Kernel Life Sciences, Fountain Healthcare Partners, Roche Venture Fund, GenenFund and Enterprise Ireland. The company was incorporated in the year 2004. Opsona is headquartered in Dublin, Ireland.
Alopexx Pharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Alopexx Pharmaceuticals, LLC (Alopexx) is a pharmaceutical company, based in the US. It develops immunotherapy for the treatment of methicillin-resistant staphylococcus aureus and also for other serious infections. The company’s compound is a human monoclonal antibody (F598) directed against dPNAG to serve as an alternative to antibiotics in the fight against those infections. Alopexx has licensed a treatment for MRSA from researchers at Beth Israel Deaconess Medical Center and Brigham and the Women’s Hospital. It is funded by the Pritzker/Vlock family office and associated trusts. The company was established in the year 2006. Alopexx is headquartered in Cambridge, Massachusetts, the US.
AiCuris GmbH & Co. KG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

AiCuris GmbH & Co. KG (AiCuris) is a pharmaceutical company, based in Germany. The company discovers, research and develops novel antibacterial and antiviral agents for the treatment of life-threatening infectious diseases. It has a broad clinical portfolio, currently developing two projects in phase II, five projects in phase I and one project in phase 0. AiCuris 10 development compounds are investigated in the indications HCMV, HSV, HIV, hepatitis B and C, and nosocomial bacterial infections. Its research projects in virology and bacteriology sustain a continuous and balanced pipeline of innovative drug candidates. The company has partnership with Bayer HealthCare and 4SC. AiCuris is headquartered in Wuppertal, Germany.
ACT Biotech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

ACT Biotech, Inc. (ACT) is a biopharmaceutical company, based in the US. It develops and commercializes cancer drugs. The company provides innovative therapies for managing cancer and underserved disease sectors where patient need is acute. It also offers novel cancer therapeutics throughout the world to improve the health and quality of life of patients. ACT focuses on conducting clinical trials for its licensed portfolio of promising drug compounds as well as to continue with its development and commercialization of new products. It has announced positive data from the Phase 2 clinical trial evaluating the novel oral antiangiogenic agent telatinib in combination with standard-of-care chemotherapy regimen as first-line treatment for patients with metastatic stomach cancer, the second most deadly tumor type in the world. The trial was conducted in multiple centers in the US. and Spain. The company has received orphan drug designation for Telatinib, an orally available and highly selective kinase inhibitor, in Gastric Cancer. The company is headquartered at San Francisco in California, the US.
Ambrx, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Ambrx, Inc. (Ambrx) is a biopharmaceutical company, based in the US. The company discovers, develops, and commercializes protein-based drugs. It has a number of differentiated product candidates at various stages of development in its pipeline, with a focus on “best in class” biopharmaceutical product opportunities. The company’s program ARX-201 is a long-acting human growth hormone. Its second advanced project is ARX424 for the treatment of multiple sclerosis. The company’s ReCODE technology confers unprecedented control over the site-directed placement of chemistry that is designed and demonstrated to be non-disruptive to protein function. Ambrx is headquartered in La Jolla, California, the US.
Eiger BioPharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Eiger BioPharmaceuticals, Inc. (Eiger) is a biopharmaceutical company, based in the US. It discovers and develops new antiviral agents against novel targets to treat hepatitis virus infection. The company’s product candidates include EBP921, EBP994 and EBP1597. It focuses on the development of new chemical entities from discovery and re-purposed clinical agents shown to possess antiviral motion against hepatitis C, hepatitis D, and a variety of other viruses. Eiger’s NS4B has four transmembrane segments responsible for conferring the protein's covering union. The company was incorporated in the year 2008. Eiger is headquartered in San Carlos, California, the US.
Arcion Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Arcion Therapeutics, Inc. (Arcion) focuses on innovative topical treatments to provide pain relief under chronic conditions. The company is into development of neuroscience to advance the treatment of chronic pain. The company focuses on innovative topical treatments to provide pain relief with convenient application and reduced systemic side effects. Arcion's product pipeline consist of ARC-4558, a gel formulation of clonidine hydrochloride for topical administration, which is currently in Phase 2b clinical trial for the treatment of painful diabetic neuropathy (PDN). Arcion intends to develop additional product candidates for the treatment of multiple chronic and neuropathic pain conditions, including post-herpetic neuralgia (PHN). On 14th june, 2011 Arcion Therapeutics presented arc-4558 phase 2b data for the treatment of pain associated with painful diabetic neuropathy. Arcion is headquartered at Baltimore in Maryland, the US.
Cardioxyl Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Cardioxyl Pharmaceuticals, Inc. (Cardioxyl) is a clinical stage biopharmaceutical company. It develops therapies for the treatment of cardiovascular disease. The company focuses on the discovery, development and marketing of novel technologies. The company's notroxyl technology is expertise in chemistry, biology and clinical applications. Cardioxyl's nitroxyl platform has produced pre-clinical and clinical candidates that include CXL-1020, for the treatment of acute decompensated heart failure. Its investors include New Enterprise Associates, Inc., and The Aurora Funds. The company was incorporated in the year 2005. Cardioxyl is headquartered in Chapel Hill, North Carolina, the US.
Pharmascience Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Pharmascience Inc. (Pharmascience) is a pharmaceutical company. It conducts the research and development, manufacturing and marketing of generic and consumer brand products for prescription and over-the-counter sale in national and international markets. The company markets its products through three business units, namely, pharmaceutical products, consumer products, and hospital and institutional products. Its drug offerings find applications in various key therapeutic areas, such as central nervous system, cardiovascular health, anti-inflammatory, gastroenterology, and anti-infectives among others. The company markets its products in the form of liquids, tablets, capsules, ophthalmic, and sterile products for inhalation, suppositories, powders, gels, injectables, nasal solutions, diagnostics, ointments, creams and medical devices. Pharmascience is headquartered in Montreal, Quebec, Canada. In January 2013, the company formed joint venture with Korea Kolmar Holdings and formed a new company named Pharmascience Korea.
Catabasis Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Catabasis Pharmaceuticals, Inc. (Catabasis) is a biopharmaceutical company, based in the US. The company conducts research and development of therapeutic products for the treatment of various types of inflammatory diseases. It develops new chemical entities (NCEs) to treat inflammatory and metabolic diseases by dramatically enhancing therapeutic potential of the essential omega-3 fatty acids, DHA and EPA. Catabasis’ proprietary chemistry platform produces new chemical entities that are conjugates of an omega-3 fatty acid and another clinically proven entity. Its therapeutic focus includes psoriasis, diabetes, inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis. Catabasis is headquartered in Cambridge, Massachusetts, the US.

Per Page: 15 25 50

2...

Clean Technology

Find premium clean technology research reports. Purchase and download high quality report analysis, environmental reports, technology reports, renewable research reports, reports on solar, wind, ethonal, algae, clean coal, and much more

DocStore Search:

DocStore » Research Reports » Clean Technology

TetraLogic Pharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PhaseBio Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cavit Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

OncoMed Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cato Research Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Opsona Therapeutics Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alopexx Pharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AiCuris GmbH & Co. KG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ACT Biotech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ambrx, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Eiger BioPharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Arcion Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cardioxyl Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmascience Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Catabasis Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile